Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
In response to myocardial infarction (MI), the wound healing response of the left ventricle (LV) consists of overlapping inflammatory, proliferative, and maturation phases; and the cardiac fibroblast is a key cell type involved in each phase. It has recently been appreciated that early post-MI, fibroblasts transform to a pro-inflammatory phenotype and secrete cytokines and chemokines as well as matrix metalloproteinases. Later post-MI, fibroblasts are activated to anti-inflammatory and pro-reparative phenotypes and generate anti-inflammatory and pro-angiogenic factors and extracellular matrix components that form the infarct scar. Additional studies are needed to systematically examine how fibroblast activation shifts over the time frame of MI response and how modulation at different activation stages could alter wound healing and LV remodeling in distinct ways. This review will summarize current fibroblast knowledge as a foundation to discuss existing knowledge gaps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596 · cited 1×
“The presence of abundant ECM may also decrease oxygen and nutrient availability to the myocardium, amplifying the pathological remodeling response [2].”
BackgroundRevisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 2×
“A transgenic collagen1α1-green fluorescent protein reporter line has been developed to track collagen 1-positive cells [15, 20].”
BackgroundGenetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 2×
“colleagues recently reported that the periostin genetic locus (PostnMCM) can be used to identify almost all subtypes of cardiac myofibroblasts [22].”
BackgroundSerini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847
A myocardial lineage derives from Tbx18 epicardial cells
Cai, C.-L., Martin, J. C., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X., Zhang, X., et al. (2008) · Nature · doi:10.1038/nature06969 · Cited by 784
Myocardial remodeling after infarction: the role of myofibroblasts
van den Borne, S. W. M., Diez, J., Blankesteijn, W. M., Verjans, J., Hofstra, L., & Narula, J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.199 · Cited by 739
Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., & Frangogiannis, N. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163017.13772.3a · Cited by 719 · cited 1×
“MCP-1 deficiency results in attenuated myofibroblast infiltration in the infarct [53, 54].”
BackgroundIdentification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699 · cited 1×
“Despite its name, FSP-1 is widely expressed in fibroblasts, leukocytes, and a number of cancer cell types [26].”
BackgroundResident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630 · cited 2×
“A transgenic collagen1α1-green fluorescent protein reporter line has been developed to track collagen 1-positive cells [15, 20].”
BackgroundResult
Cited by
Guidelines for experimental models of myocardial ischemia and infarction
Lindsey, M. L., Bolli, R., Canty, J. M., Du, X.-J., Frangogiannis, N. G., Frantz, S., Gourdie, R. G., Holmes, J. W., Jones, S. P., Kloner, R. A., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2017 · Cited by 526
Self-citationMa, Y., Mouton, A. J., & Lindsey, M. L. (2018) · Translational Research · doi:10.1016/j.trsl.2017.10.001 · Cited by 405
“Conversion of these initial models into logic-based distinct equations will provide a window for simulations with other key players that may be identified to build on the existing framework.(142) The in silico integration of complex data sets can help define key trigger point responses, combined with bioinformatics an…”
BackgroundSelf-citationComparative regenerative mechanisms across different mammalian tissues
Iismaa, S. E., Kaidonis, X., Nicks, A. M., Bogush, N., Kikuchi, K., Naqvi, N., Harvey, R. P., Husain, A., & Graham, R. M. (2018) · npj Regenerative Medicine · doi:10.1038/s41536-018-0044-5 · Cited by 253
Metadata
- Authors
- Ma, Y., Iyer, R. P., Jung, M., Czubryt, M. P., & Lindsey, M. L.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 38
- Issue
- 5
- Pages
- 448-458
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2598923058
- Cited by
- 202
- References
- 83
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.